By degrading PIP3, PTEN effectively counterbalances the activation of the oncogenic PI3K/AKT/mTOR signaling pathway, exerting profound effects on tumor cell cycle progression, apoptosis, tumor invasiveness, and angiogenesis [60]. The gene discussed is PTEN; the disease is neoplasm.